APA (7th ed.) Citation

Pointeau, O., Ba, A. I., Geissler, A., Barbosa, R., Basu, A., Muhammad, A., . . . Cinar, R. (2025). Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy. British Journal of Pharmacology, 182(21), 5355. https://doi.org/10.1111/bph.70118

Chicago Style (17th ed.) Citation

Pointeau, Océane, et al. "Blockade of Cannabinoid CB1 Receptors Potentiates the Anti‐fibrotic Effects Mediated by SGLT2 Inhibition in a Mouse Model of Diabetic Nephropathy." British Journal of Pharmacology 182, no. 21 (2025): 5355. https://doi.org/10.1111/bph.70118.

MLA (9th ed.) Citation

Pointeau, Océane, et al. "Blockade of Cannabinoid CB1 Receptors Potentiates the Anti‐fibrotic Effects Mediated by SGLT2 Inhibition in a Mouse Model of Diabetic Nephropathy." British Journal of Pharmacology, vol. 182, no. 21, 2025, p. 5355, https://doi.org/10.1111/bph.70118.